Subcellular localization of IRS-1 in IGF-I-mediated chondrogenic proliferation, differentiation and hypertrophy of bone marrow mesenchymal stem cells

Growth Factors

Volumn 27, Issue 5, 2009, Pages 309-320

  Longobardi, Lara ^a   Granero Moltó, Froilán ^a   O'Rear, Lynda ^b   Myers, Timothy J ^a   Li, Tieshi ^a   Kregor, Philip J ^b   Spagnoli, Anna ^a,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Cell signalling; Chondrocyte differentiation; IGF I; IRS 1; Mesenchymal stem cells

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE B; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BONE MARROW CELL; CARTILAGE CELL; CELL FATE; CELL PROLIFERATION; CELL STIMULATION; CELLULAR DISTRIBUTION; CHONDROGENESIS; CONTROLLED STUDY; CYTOPLASM; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPERTROPHY; MESENCHYMAL STEM CELL; MITOGENESIS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; HUMANS; HYPERTROPHY; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

MUS;

EID: 70349411641     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190903138874     Document Type: Article

References (66)

1. Aplin AE, Juliano RL. 2001. Regulation of nucleocytoplasmic trafficking by cell adhesion receptors and the cytoskeleton. J Cell Biol 155:187-191.
2. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B, 3rd, Johnson RS, Kahn CR. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372: 186-190.
3. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG. 2003. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 89:1235-1249.
4. Barry FP, Murphy JM. 2004. Mesenchymal stem cells: Clinical applications and biological characterization. Int J Biochem Cell Biol 36:568-584.
5. Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B. 1997. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1332:F105-F126.
6. Boney CM, Fiedorek FT, Jr, Paul SR, Gruppuso PA. 1996. Regulation of preadipocyte factor-1 gene expression during 3T3- L1 cell differentiation. Endocrinology 137:2923-2928.
7. Bradley LM, Gierthy JF, Pentecost BT. 2008. Role of the insulinlike growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line. J Steroid Biochem Mol Biol 109:185-196.
8. Carmo-Fonseca M. 2002. The contribution of nuclear compartmentalization to gene regulation. Cell 108:513-521.
9. Cesarone G, Garofalo C, Abrams MT, Igoucheva O, Alexeev V, Yoon K, Surmacz E, Wickstrom E. 2006. RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells. J Cell Biochem 98:440-450.
10. Cesarone G, Edupuganti OP, Chen CP,Wickstrom E. 2007. Insulin receptor substrate 1 knockdown in human MCF7 ER + breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged D-peptide analogue of insulin-like growth factor 1. Bioconjug Chem 18:1831-1840.
11. Chen J,Wu A, Sun H, Drakas R, Garofalo C, Cascio S, Surmacz E, Baserga R. 2005. Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and beta-catenin. J Biol Chem 280: 29912-29920.
12. Choi SC, Kim SJ, Choi JH, Park CY, Shim WJ, Lim DS. 2008. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Stem Cells Dev 17: 725-736.
13. Cristofanelli B, Valentinis B, Soddu S, Rizzo MG, Marchetti A, Bossi G, Morena AR, Dews M, Baserga R, Sacchi A. 2000. Cooperative transformation of 32D cells by the combined expression of IRS-1 and V-Ha-Ras. Oncogene 19:3245-3255.
14. Daniely Y, Dimitrova DD, Borowiec JA. 2002. Stress-dependent nucleolin mobilization mediated by p53-nucleolin complex formation. Mol Cell Biol 22:6014-6022.
15. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241.
16. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, NunezG. 1997. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687-689.
17. Dupont J, Holzenberger M. 2003. Biology of insulin-like growth factors in development. Birth Defects Res Part C Embryo Today 69:257-271.
18. Fernandes JC, Martel-Pelletier J, Pelletier JP. 2002. The role of cytokines in osteoarthritis pathophysiology. Biorheology 39: 237-246.
19. Florini JR, Ewton DZ, Falen SL, Van Wyk JJ. 1986. Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins. Am J Physiol 250:C771-C778.
20. Fortier LA, Balkman CE, Sandell LJ, Ratcliffe A, Nixon AJ. 2001. Insulin-like growth factor-I gene expression patterns during spontaneous repair of acute articular cartilage injury. J Orthop Res 19:720-728.
21. Francis GL, Ross M, Ballard FJ, Milner SJ, Senn C, McNeil KA, Wallace JC, King R, Wells JR. 1992. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. J Mol Endocrinol 8: 213-223.
22. Francis GL, Aplin SE, Milner SJ, McNeil KA, Ballard FJ, Wallace JC. 1993. Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II. Biochem J 293(Pt 3): 713-719.
23. Jans DA, Hassan G. 1998. Nuclear targeting by growth factors, cytokines, and their receptors: A role in signaling? Bioessays 20: 400-411.
24. Johnstone B, Yoo JU. 1999. Autologous mesenchymal progenitor cells in articular cartilage repair. Clin Orthop 367:S156-S162.
25. Johnstone B, Yoo J. 2001. Mesenchymal cell transfer for articular cartilage repair. Expert Opin Biol Ther 1:915-921.
26. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. 1998. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238:265-272.
27. Lanzino M, Garofalo C, Morelli C, Le Pera M, Casaburi I, McPhaul MJ, Surmacz E, Ando S, Sisci D. 2009. Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells. Breast Cancer Res Treat. 115:297-306.
28. Lassak A, Del Valle L, Peruzzi F, Wang JY, Enam S, Croul S, Khalili K, Reiss K. 2002. Insulin receptor substrate 1 translocation to the nucleus by the human JC virus T-antigen. J Biol Chem 277:17231-17238.
29. LeRoith D, Roberts CT, Jr. 2003. The insulin-like growth factor system and cancer. Cancer Lett 195:127-137.
30. Longobardi L, O'Rear L, Aakula S, Johnstone B, Shimer K, Chytil A, Horton WA, Moses HL, Spagnoli A. 2006. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res 21:626-636.
31. Luyten FP, Hascall VC, Nissley SP, Morales TI, Reddi AH. 1988. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants. Arch Biochem Biophys 267:416-425.
32. Martel-Pelletier J, Di Battista JA, Lajeunesse D, Pelletier JP. 1998. IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis. Inflamm Res 47:90-100.
33. McMorris FA, Smith TM, DeSalvo S, Furlanetto RW. 1986. Insulin-like growth factor I/somatomedin C: A potent inducer of oligodendrocyte development. Proc Natl Acad Sci USA 83: 822-826.
34. Milasincic DJ, Calera MR, Farmer SR, Pilch PF. 1996. Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways. Mol Cell Biol 16:5964-5973.
35. Mill JF, Chao MV, Ishii DN. 1985. Insulin, insulin-like growth factor II, and nerve growth factor effects on tubulin mRNA levels and neurite formation. Proc Natl Acad Sci USA 82:7126-7130.
36. Morelli C, Garofalo C, Sisci D, del Rincon S, Cascio S, Tu X, Vecchione A, Sauter ER, Miller WH, Jr, Surmacz E. 2004. Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters. Oncogene 23:7517-7526.
37. Murphy JM, Fink DJ, Hunziker EB, Barry FP. 2003. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48: 3464-3474.
38. Oh CD, Chun JS. 2003. Signaling mechanisms leading to the regulation of differentiation and apoptosis of articular chondrocytes by insulin-like growth factor-1. J Biol Chem 278: 36563-36571.
39. Parrizas M, LeRoithD. 1997. Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product. Endocrinology 138:1355-1358.
40. Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B, Baserga R. 1999. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 19:7203-7215.
41. Pete G, Fuller CR, Oldham JM, Smith DR, D'Ercole AJ, Kahn CR, Lund PK. 1999. Postnatal growth responses to insulin-like growth factor I in insulin receptor substrate-1-deficient mice. Endocrinology 140:5478-5487.
42. Phornphutkul C, Wu KY, Yang X, Chen Q, Gruppuso PA. 2004. Insulin-like growth factor-I signaling is modified during chondrocyte differentiation. J Endocrinol 183:477-486.
43. Prisco M, Santini F, Baffa R, Liu M, Drakas R, Wu A, Baserga R. 2002. Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 Tantigen and the activated type 1 insulin-like growth factor receptor. J Biol Chem 277:32078-32085.
44. Schmid C, Steiner T, Froesch ER. 1984. Insulin-like growth factor I supports differentiation of cultured osteoblast-like cells. FEBS Lett 173:48-52.
45. Sekiya I, Vuoristo JT, Larson BL, Prockop DJ. 2002. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci USA 99: 4397-4402.
46. Shima H, Pende M, Chen Y, Fumagalli S, Thomas G, Kozma SC. 1998. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 17: 6649-6659.
47. Simmons JG, Ling Y, Wilkins H, Fuller CR, D'Ercole AJ, Fagin J, Lund PK. 2007. Cell-specific effects of insulin receptor substrate-1 deficiency on normal and IGF-I-mediated colon growth. Am J Physiol Gastrointest Liver Physiol 293:G995-1003.
48. Sionov RV, Coen S, Goldberg Z, Berger M, Bercovich B, Ben-Neriah Y, Ciechanover A, Haupt Y. 2001. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination. Mol Cell Biol 21: 5869-5878.
49. Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS. 1988. Insulinlike growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 263:9402-9408.
50. Spagnoli A, Longobardi L, O'Rear L. 2004. Cartilage disorders. Potential therapeutic use of mesenchymal stem cells. Endocr Dev 9:17-30. Review.
51. Spagnoli A, Longobardi L, O'Rear L. 2005. Cartilage disorders: Potential therapeutic use of mesenchymal stem cells. Endocr Dev 9:17-30.
52. Spagnoli A, O'Rear L, Chandler RL, Granero-Molto F, Mortlock DP, Gorska AE, Weis JA, Longobardi L, Chytil A, Shimer K, Moses HL. 2007. TGF-beta signaling is essential for joint morphogenesis. J Cell Biol 177:1105-1117.
53. Sun H, Baserga R. 2008. The role of insulin receptor substrate-1 in transformation by v-src. J Cell Physiol 215:725-732.
54. Sun H, Tu X, Prisco M,Wu A, Casiburi I, Baserga R. 2003. Insulinlike growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2. Mol Endocrinol 17: 472-486.
55. Tardif G, Reboul P, Pelletier JP, Geng C, Cloutier JM, Martel-Pelletier J. 1996. Normal expression of type 1 insulinlike growth factor receptor by human osteoarthritic chondrocytes with increased expression and synthesis of insulin-like growth factor binding proteins. Arthritis Rheum 39:968-978.
56. Tu X, Batta P, Innocent N, Prisco M, Casaburi I, Belletti B, Baserga R. 2002. Nuclear translocation of insulin receptor substrate-1 by oncogenes and Igf-I. Effect on ribosomal RNA synthesis. J Biol Chem 277:44357-44365.
57. Tu X, Baffa R, Luke S, Prisco M, Baserga R. 2003a. Intracellular redistribution of nuclear and nucleolar proteins during differentiation of 32D murine hemopoietic cells. Exp Cell Res 288:119-130.
58. Tu X, Wu A, Maiorana A, Baserga R. 2003b. Subcellular localization of IRS-1 in cell proliferation and differentiation. Horm Metab Res 35:734-739.
59. Tu X,Wu A, Maiorana A, Baserga R. 2004. Subcellular localization of IRS-1 in cell proliferation and differentiation. Horm Metab Res 36:72.
60. Valentinis B, Romano G, Peruzzi F, Morrione A, Prisco M, Soddu S, Cristofanelli B, Sacchi A, Baserga R. 1999. Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways. J Biol Chem 274:12423-12430.
61. Valentinis B, Navarro M, Zanocco-Marani T, Edmonds P, McCormick J, Morrione A, Sacchi A, Romano G, Reiss K, Baserga R. 2000. Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells. J Biol Chem 275:25451-25459.
62. White MF. 1998. The IRS-signalling system: A network of docking proteins that mediate insulin action. Mol Cell Biochem 182: 3-11.
63. Wu A, Chen J, Baserga R. 2008. Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes. Oncogene 27:397-403.
64. Yaeger PC, Masi TL, de Ortiz JL, Binette F, Tubo R, McPherson JM. 1997. Synergistic action of transforming growth factor-beta and insulin-like growth factor-I induces expression of type II collagen and aggrecan genes in adult human articular chondrocytes. Exp Cell Res 237:318-325.
65. Yang H, Xia Y, Lu SQ, Soong TW, Feng ZW. 2008. Basic fibroblast growth factor-induced neuronal differentiation of mouse bone marrow stromal cells requires FGFR-1, MAPK/ERK, and transcription factor AP-1. J Biol Chem 283:5287-5295.
66. Yoo JU, Mandell I, Angele P, Johnstone B. 2000. Chondrogenitor cells and gene therapy. Clin Orthop 379S:S164-S170.